Keiji Fukuda (født 1955 i USA) er en amerikansk medisiner med ekspertise innen forskning på influensaepidemiologi. I mars 2009 ble han utnevnt til assisterende generaldirektør ad interim for Verdens helseorganisasjons avdeling for «Health, Security and Environment» Han er basert i Genève i Sveits.


== Biografi ==
Fukudas foreldre var leger; faren emigrerte fra Japan til Vermont i USA under sin utdannelse, og tok etterpå arbeid ved et sykehus i Barre i Vermont. Keiji Fukuda tok sin høyere utdannelse ved Oberlin College, University of Vermont College of Medicine (1983) og Mount Zion Hospital i San Francisco og ved University of California, Berkeley. Under studiene arbeidet han i en periode blant stammefolk i Sør-India.
Han har arbeidet med spedalskhet og tuberkulose, og spesialiserte seg senere i epidemologi i Atlanta. Han er også en ekspert på kronisk utmattelsessyndrom.
Han har fokusert på influensa siden 1996, og ledet team som forsket på utbrudd av fugleinfluensa og SARS.
Den 28. april 2009 fastslo han at det allerede var for sent å prøve å demme opp for en internasjonal spredning av svineinfluensaen som var brutt ut i Mexico.


== Publikasjoner ==
Avian influenza A (H5N1) virus and 2 fundamental questions. Briand S, Fukuda K. J Infect Dis. 2009 Jun 15;199(12):1717-9.
The pandemic influenza vaccine challenge. Kieny MP, Fukuda K. Vaccine. 2008 Sep 12;26 Suppl 4:D3-4.
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus Schünemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, Hayden FG, Yazdanpanah Y, Beigel J, Chotpitayasunondh T, Del Mar C, Farrar J, Tran TH, Ozbay B, Sugaya N, Fukuda K, Shindo N, Stockman L, Vist GE, Croisier A, Nagjdaliyev A, Roth C, Thomson G, Zucker H, Oxman AD; WHO Rapid Advice Guideline Panel on Avian Influenza. Lancet Infect Dis. 2007 Jan;7(1):21-31. Review.
Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Emerg Infect Dis. 2006 Oct;12(10):1548-58.
Different approaches to influenza vaccination. Fukuda K, Kieny MP.N Engl J Med. 2006 Dec 14;355(24):2586-7.
Influenza-associated deaths among children in the United States, 2003-2004. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL, Klimov A, Lindstrom SE, Balish A, Medina MJ, Wallis TR, Guarner J, Paddock CD, Shieh WJ, Zaki SR, Sejvar JJ, Shay DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM; Influenza Special Investigations Team. N Engl J Med. 2005 Dec 15;353(24):2559-67.
Influenza vaccination among the elderly in the United States. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox NJ, Fukuda K. Arch Intern Med. 2005 Sep 26;165(17):2038-9; author reply 2039-40
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2005 Jul 29;54(RR-8):1-40. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Aug 5;54(30):750..
Values for preventing influenza-related morbidity and vaccine adverse events in children. Prosser LA, Bridges CB, Uyeki TM, Rêgo VH, Ray GT, Meltzer MI, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Health Qual Life Outcomes. 2005 Mar 21;3:18.
An economic analysis of annual influenza vaccination of children. Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. Vaccine. 2005 Jan 11;23(8):1004-14.
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Bridges CB, Winquist AG, Fukuda K, Cox NJ, Singleton JA, Strikas RA; Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2000 Apr 14;49(RR-3):1-38; quiz CE1-7.


== Referanser ==


== Eksterne lenker ==
Keiji Fukuda i World Health Organization